These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2898284)

  • 1. Hypofrontality in schizophrenia.
    Jones BD
    Can J Psychiatry; 1988 Apr; 33(3):243-5. PubMed ID: 2898284
    [No Abstract]   [Full Text] [Related]  

  • 2. Akinesia, tardive dysmentia, and frontal lobe disorder in schizophrenia.
    Goldberg E
    Schizophr Bull; 1985; 11(2):255-63. PubMed ID: 2861656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction.
    Falkai P; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):83-4. PubMed ID: 21328016
    [No Abstract]   [Full Text] [Related]  

  • 4. Marked hypofrontality in clozapine-responsive patients.
    Molina V; Sanz J; Sarramea F; Palomo T
    Pharmacopsychiatry; 2007 Jul; 40(4):157-62. PubMed ID: 17694479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of antipsychotics on brain structure: what have we learnt from structural imaging of schizophrenia?
    Borgwardt SJ; Smieskova R; Fusar-Poli P; Bendfeldt K; Riecher-Rössler A
    Psychol Med; 2009 Nov; 39(11):1781-2. PubMed ID: 19476691
    [No Abstract]   [Full Text] [Related]  

  • 6. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
    Himelhoch S; Taylor SF; Goldman RS; Tandon R
    Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
    [No Abstract]   [Full Text] [Related]  

  • 7. Mortality in patients with schizophrenia.
    Dervaux A; Laqueille X
    Lancet; 2009 Nov; 374(9701):1592; author reply 1592-3. PubMed ID: 19897120
    [No Abstract]   [Full Text] [Related]  

  • 8. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quetiapine and the potential for abuse].
    Aa E; Helland A; Spigset O
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1619-20. PubMed ID: 22875127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of neuroleptics on the frontal functions of schizophrenics].
    Verdoux H; Magnin E; Bourgeois M
    Ann Med Psychol (Paris); 1994 Oct; 152(8):530-4. PubMed ID: 7818228
    [No Abstract]   [Full Text] [Related]  

  • 12. Diphenhydramine dependence: a need for awareness.
    de Nesnera AP
    J Clin Psychiatry; 1996 Mar; 57(3):136-7. PubMed ID: 8617701
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological treatment of schizophrenia and co-occurring substance use disorders.
    Smelson DA; Dixon L; Craig T; Remolina S; Batki SL; Niv N; Owen R
    CNS Drugs; 2008; 22(11):903-16. PubMed ID: 18840032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia.
    Nesvåg R; Frigessi A; Jönsson EG; Agartz I
    Schizophr Res; 2007 Feb; 90(1-3):52-61. PubMed ID: 17218084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting hypofrontality in schizophrenia: A study using near-infrared time-resolved spectroscopy.
    Hoshi Y; Shinba T; Sato C; Doi N
    Schizophr Res; 2006 Jun; 84(2-3):411-20. PubMed ID: 16626944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal lobotomy and hypofrontality in patients with schizophrenia: an integration of the findings.
    Goumeniouk AD; Clark CM
    Can J Psychiatry; 1992 Feb; 37(1):17-22. PubMed ID: 1348011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can antipsychotic treatment contribute to drug addiction in schizophrenia?
    Samaha AN
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():9-16. PubMed ID: 23793001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychobiology of first-episode schizophrenia.
    Waring EM
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S33-7. PubMed ID: 8564915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of clozapine on cognitive function and regional cerebral blood flow in the negative symptom profile schizophrenia.
    Zhao J; He X; Liu Z; Yang D
    Int J Psychiatry Med; 2006; 36(2):171-81. PubMed ID: 17154147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory symptomatic schizophrenia resulting from frontal lobe lesion: response to clozapine.
    Burke JG; Dursun SM; Reveley MA
    J Psychiatry Neurosci; 1999 Nov; 24(5):456-61. PubMed ID: 10586537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.